Provider reported implementation barriers to hepatitis C elimination in Washington State

Autor: Paula Cox-North, Lisa Wiggins, Jon Stockton, Emalie Huriaux, Mary Fliss, Leta Evaskus, Kenneth Pike, Anirban Basu, Pamela Kohler
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: BMC Primary Care, Vol 25, Iss 1, Pp 1-10 (2024)
Druh dokumentu: article
ISSN: 2731-4553
DOI: 10.1186/s12875-024-02507-0
Popis: Abstract Background Despite curative treatment options since 2014, only 12% of individuals in Washington State diagnosed with Hepatitis C (HCV) received treatment in 2018. Washington State agencies launched an elimination plan in 2019 to promote access to and delivery of HCV screening and treatment. The purpose of this study is to evaluate provider and health system barriers to successful implementation of HCV screening and treatment across Washington State. Methods This is a cross-sectional online survey of 547 physicians, nurse practitioners, physician assistants, and clinical pharmacists who provide care to adult patients in Washington State conducted in 2022. Providers were eligible if they worked in a primary care, infectious disease, gastroenterology, or community health settings. Questions assessed HCV screening and treating practices, implementation barriers, provider knowledge, observed stigma, and willingness to co-manage HCV and substance use disorder. Chi-squared or fishers exact tests compared characteristics of those who did and did not screen or treat. Results Provider adoption of screening for HCV was high across the state (96%), with minimal barriers identified. Fewer providers reported treating HCV themselves (28%); most (71%) referred their patients to another provider. Barriers identified by those not treating HCV included knowledge deficit (64%) and lack of organizational support (24%). The barrier most identified in those treating HCV was a lack of treating clinicians (18%). There were few (
Databáze: Directory of Open Access Journals
Nepřihlášeným uživatelům se plný text nezobrazuje